Consistent with the report of granzyme B’s being a useful predictive imaging biomarker for immunotherapy (33), our data showed that granzyme B expression negatively correlated with tumor weight, with an exponential increase in weight with decreasing granzyme B expression (Fig. 4C). Here, GZMB is linked to neoplasm.